Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCuttm - the world's first ...

This is designed to treat patients who had previously undergone ascending aorta replacement requiring a second operation to treat the arch and descending aorta and presenting with an aortic aneurysm ...

Aortic growth and elongation have been suggested as risk ... Among these, 74 (70.5%) individuals had a history of root/ascending repair (ARR), of which 17 (16.2%) were due to a history of repaired ...

The On-X Aortic Heart Valve and On-X Ascending Aortic Prosthesis with the Vascutek Gelweave ... from approximately 60 sites in North America who underwent aortic valve replacement at least 3 months ...

Patients at Baylor Medicine, the primary multidisciplinary clinical practice of Baylor College of Medicine, and Baylor St.

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...

Background: There are insufficient data regarding how to deal with moderate aortic valve (AV) dysfunction during rheumatic mitral valve (MV) surgery. In this study, the clinical outcomes of patients ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

HEMASHIELD PLATINUM Woven Double Velour Grafts are collagen-impregnated and come in straight, one-branch, or multi-branch graft configurations for aortic repair. Trusted for more than 20 years ...

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...